NO20070983L - Stabil injiserbar blanding av alfa-tokoferylsuksinat, analoger og salter derav - Google Patents
Stabil injiserbar blanding av alfa-tokoferylsuksinat, analoger og salter deravInfo
- Publication number
- NO20070983L NO20070983L NO20070983A NO20070983A NO20070983L NO 20070983 L NO20070983 L NO 20070983L NO 20070983 A NO20070983 A NO 20070983A NO 20070983 A NO20070983 A NO 20070983A NO 20070983 L NO20070983 L NO 20070983L
- Authority
- NO
- Norway
- Prior art keywords
- analogs
- alpha
- salts
- tocopheryl succinate
- stable injectable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Foreliggende oppfinnelse tilveiebringer sammensetninger som omfatter alfatokoferylsuksinat eller dens analog eller salt og fremgangsmåter for fremstilling av og anvendelse av slike sammensetninger.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59209704P | 2004-07-28 | 2004-07-28 | |
PCT/US2005/026783 WO2006015120A2 (en) | 2004-07-28 | 2005-07-28 | Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20070983L true NO20070983L (no) | 2007-02-27 |
Family
ID=35787824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20070983A NO20070983L (no) | 2004-07-28 | 2007-02-21 | Stabil injiserbar blanding av alfa-tokoferylsuksinat, analoger og salter derav |
Country Status (11)
Country | Link |
---|---|
US (1) | US20060024360A1 (no) |
EP (1) | EP1778217A4 (no) |
JP (1) | JP2008508302A (no) |
KR (1) | KR20070059072A (no) |
CN (1) | CN1925853B (no) |
AU (1) | AU2005269383A1 (no) |
CA (1) | CA2575216A1 (no) |
IL (1) | IL180741A0 (no) |
NO (1) | NO20070983L (no) |
RU (1) | RU2007107359A (no) |
WO (1) | WO2006015120A2 (no) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7871632B2 (en) * | 2004-07-12 | 2011-01-18 | Adventrx Pharmaceuticals, Inc. | Compositions for delivering highly water soluble drugs |
US8557861B2 (en) | 2004-09-28 | 2013-10-15 | Mast Therapeutics, Inc. | Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
US20080038316A1 (en) * | 2004-10-01 | 2008-02-14 | Wong Vernon G | Conveniently implantable sustained release drug compositions |
TWI376239B (en) * | 2006-02-01 | 2012-11-11 | Andrew Xian Chen | Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
CN101011355B (zh) * | 2006-02-01 | 2013-01-02 | 陈献 | 经维生素e琥珀酸酯稳定的医药组合物、其制备及用途 |
WO2007139930A2 (en) * | 2006-05-26 | 2007-12-06 | Bayer Healthcare Llc | Drug combinations with substituted diaryl ureas for the treatment of cancer |
CA2663474C (en) | 2006-09-15 | 2017-06-27 | Griffith University | Pro-oxidant anti-cancer compounds |
NZ555163A (en) * | 2007-05-14 | 2010-05-28 | Fonterra Co Operative Group | Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments |
MX2009013663A (es) * | 2007-06-22 | 2010-01-27 | Scidose Llc | Formulacion solubilizada de docetaxel sin tween 80. |
EP2265623B1 (en) | 2008-03-14 | 2016-07-13 | Cancure Limited | Mitochondrially delivered anti-cancer compounds |
US20100260830A1 (en) * | 2009-04-08 | 2010-10-14 | Brian A Salvatore | Liposomal Formulations of Tocopheryl Amides |
US8568745B2 (en) | 2009-07-09 | 2013-10-29 | Kyushu University, National University Corporation | Water-soluble drug carrier and process for producing the same |
WO2011019710A2 (en) * | 2009-08-10 | 2011-02-17 | Proviflo, Llc | Catheter lock solutions utilizing tocopheraol and mid-chain fatty acids |
JP2013503166A (ja) * | 2009-08-25 | 2013-01-31 | カーディオカイン・バイオファーマ・エルエルシー | 不溶性剤を送達するための組成物 |
US8476310B2 (en) | 2009-10-19 | 2013-07-02 | Scidose Llc | Docetaxel formulations with lipoic acid |
US7772274B1 (en) | 2009-10-19 | 2010-08-10 | Scidose, Llc | Docetaxel formulations with lipoic acid |
US20110092579A1 (en) * | 2009-10-19 | 2011-04-21 | Scidose Llc | Solubilized formulation of docetaxel |
US8541465B2 (en) * | 2009-10-19 | 2013-09-24 | Scidose, Llc | Docetaxel formulations with lipoic acid and/or dihydrolipoic acid |
US8912228B2 (en) | 2009-10-19 | 2014-12-16 | Scidose Llc | Docetaxel formulations with lipoic acid |
UA110383C2 (en) * | 2011-06-08 | 2015-12-25 | Akzo Nobel Chemicals Int Bv | Deicing composition |
PL2718386T3 (pl) | 2011-06-08 | 2016-07-29 | Akzo Nobel Chemicals Int Bv | Kompozycja przeciwoblodzeniowa |
AR088524A1 (es) | 2011-11-09 | 2014-06-18 | Akzo Nobel Chemicals Int Bv | Composicion descongelante, proceso de preparacion, conjunto de parte y uso |
RU2664700C2 (ru) | 2012-05-10 | 2018-08-21 | Пейнреформ Лтд. | Депо-составы местного анестетика и способы их получения |
JP6094388B2 (ja) * | 2013-06-07 | 2017-03-15 | ニプロ株式会社 | ペメトレキセドを含む注射用組成物 |
JP6087769B2 (ja) * | 2013-08-30 | 2017-03-01 | サントリー食品インターナショナル株式会社 | 烏龍茶抽出物を含有する容器詰飲料 |
WO2016201269A2 (en) | 2015-06-11 | 2016-12-15 | Proviflo, Llc | Graft-port hemodialysis systems, devices and methods |
US11229602B2 (en) * | 2016-01-07 | 2022-01-25 | Western University Of Health Sciences | Formulations for treating bladder cancer |
US20200138855A1 (en) * | 2017-07-20 | 2020-05-07 | Delta-Fly Pharma, Inc. | Novel antineoplastic drug based on specificity of cancer-cell metabolism |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3173838A (en) * | 1962-03-28 | 1965-03-16 | Eastman Kodak Co | Solid, vitamin e-active product and process for making it |
US4783220A (en) * | 1986-12-18 | 1988-11-08 | Xerox Corporation | Vesicle ink compositions |
CA2130357A1 (en) * | 1992-02-18 | 1993-08-19 | Doron Friedman | Dry compositions for preparing submicron emulsions |
US5961970A (en) * | 1993-10-29 | 1999-10-05 | Pharmos Corporation | Submicron emulsions as vaccine adjuvants |
GB9409778D0 (en) * | 1994-05-16 | 1994-07-06 | Dumex Ltd As | Compositions |
GB9514878D0 (en) * | 1995-07-20 | 1995-09-20 | Danbiosyst Uk | Vitamin E as a solubilizer for drugs contained in lipid vehicles |
US6727280B2 (en) * | 1997-01-07 | 2004-04-27 | Sonus Pharmaceuticals, Inc. | Method for treating colorectal carcinoma using a taxane/tocopherol formulation |
US6458373B1 (en) * | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
US7030155B2 (en) * | 1998-06-05 | 2006-04-18 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
US20030236236A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
US20030005407A1 (en) * | 2000-06-23 | 2003-01-02 | Hines Kenneth J. | System and method for coordination-centric design of software systems |
US20030099674A1 (en) * | 2001-08-11 | 2003-05-29 | Chen Andrew X. | Lyophilized injectable formulations containing paclitaxel or other taxoid drugs |
US20040175415A1 (en) * | 2003-03-05 | 2004-09-09 | Chan Alvin C. | Formulations and methods of delivery of intact tocopheryl succinate to humans |
US7871632B2 (en) * | 2004-07-12 | 2011-01-18 | Adventrx Pharmaceuticals, Inc. | Compositions for delivering highly water soluble drugs |
-
2005
- 2005-07-28 JP JP2007523807A patent/JP2008508302A/ja not_active Withdrawn
- 2005-07-28 RU RU2007107359/15A patent/RU2007107359A/ru not_active Application Discontinuation
- 2005-07-28 AU AU2005269383A patent/AU2005269383A1/en not_active Abandoned
- 2005-07-28 CA CA002575216A patent/CA2575216A1/en not_active Abandoned
- 2005-07-28 WO PCT/US2005/026783 patent/WO2006015120A2/en active Application Filing
- 2005-07-28 US US11/192,439 patent/US20060024360A1/en not_active Abandoned
- 2005-07-28 CN CN2005800020729A patent/CN1925853B/zh not_active Expired - Fee Related
- 2005-07-28 KR KR1020077004963A patent/KR20070059072A/ko not_active Application Discontinuation
- 2005-07-28 EP EP05779446A patent/EP1778217A4/en not_active Withdrawn
-
2007
- 2007-01-16 IL IL180741A patent/IL180741A0/en unknown
- 2007-02-21 NO NO20070983A patent/NO20070983L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20070059072A (ko) | 2007-06-11 |
JP2008508302A (ja) | 2008-03-21 |
CA2575216A1 (en) | 2006-02-09 |
CN1925853A (zh) | 2007-03-07 |
IL180741A0 (en) | 2007-07-04 |
EP1778217A4 (en) | 2008-10-08 |
WO2006015120A3 (en) | 2006-05-18 |
RU2007107359A (ru) | 2008-09-10 |
US20060024360A1 (en) | 2006-02-02 |
EP1778217A2 (en) | 2007-05-02 |
AU2005269383A1 (en) | 2006-02-09 |
WO2006015120A2 (en) | 2006-02-09 |
CN1925853B (zh) | 2011-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20070983L (no) | Stabil injiserbar blanding av alfa-tokoferylsuksinat, analoger og salter derav | |
WO2018136202A3 (en) | Compounds and methods for cdk8 modulation and indications therefor | |
UA112281C2 (uk) | Стабільні інсектицидні композиції і способи їх отримання | |
SV2004001690A (es) | Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
CY1114539T1 (el) | Η χρησιμοτητα των ιμιδαζοπυριδαζινοκαρβονιτριλιων ως αναστολεων κινασων | |
MX2009003958A (es) | Nuevos derivados de 1,4-benzotiepina-1,1-dioxido sustituidos con radicales bencilo, metodo para su preparacion, productos farmaceuticos que comprenden estos compuestos y su uso. | |
ATE433447T1 (de) | Pyrimiidinverbindungen | |
ECSP099357A (es) | COMPUESTOS QUE MODULAN ACTIVIDAD C-FMS y/o C-KIT Y USOS PARA ELLO | |
BRPI0514444A (pt) | análogos de ciclopamina e métodos de uso destes | |
NO20071078L (no) | Antivirale forbindelser | |
NO20070866L (no) | Antivirale forbindelser. | |
NO20075082L (no) | Pyridin-3-karboksamidderivater som CB1-inversagonister | |
DOP2010000396A (es) | Derivado de uracilo o timina para el tratamiento de hepatitis c | |
NO20085183L (no) | Stabiliserte insulinlignende vekstfaktorpolypeptider | |
TN2009000163A1 (en) | Compounds and compositions as protein kinase inibitors | |
TW200642700A (en) | Chemically defined stabiliser | |
NO20090295L (no) | Substituerte heteroarylderivater | |
WO2012080284A3 (en) | Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof | |
NO20082023L (no) | Pyrrolotriazin kinaseinhibitorer | |
ATE293119T1 (de) | Cardioprotektive phosphonate | |
WO2008002571A3 (en) | Human protein tyrosine phosphatase inhibitors and methods of use | |
NO20082124L (no) | Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom | |
NO20076638L (no) | Nye 8-sulfonylamino-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptoren | |
BRPI0608819B8 (pt) | formas cristalinas de um derivado de imidazol | |
GT200600199A (es) | Diarilsulfonas sulfonamidas y su uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |